scholarly journals Physiological Effects of High-Flow Nasal Cannula Therapy and Its Use in Acute Cardiogenic Pulmonary Edema

Cureus ◽  
2021 ◽  
Author(s):  
Prakash Adhikari ◽  
Sanket Bhattarai ◽  
Ashish Gupta ◽  
Eiman Ali ◽  
Moeez Ali ◽  
...  
Keyword(s):  
Pulmonary Edema ◽  
High Flow ◽  
Nasal Cannula ◽  
Cardiogenic Pulmonary Edema ◽  
Physiological Effects ◽  
High Flow Nasal Cannula ◽  
Acute Cardiogenic Pulmonary Edema

scholarly journals High-Flow Nasal Cannula Therapy in a Patient with Reperfusion Pulmonary Edema following Percutaneous Transluminal Pulmonary Angioplasty

2014 ◽  
Vol 2014 ◽  
pp. 1-5 ◽  
Author(s):  
Kiyoshi Moriyama ◽  
Toru Satoh ◽  
Akira Motoyasu ◽  
Tomoki Kohyama ◽  
Mariko Kotani ◽  
...  
Keyword(s):  
Pulmonary Edema ◽  
Chronic Thromboembolic Pulmonary Hypertension ◽  
Heart Association ◽  
High Flow ◽  
Nasal Cannula ◽  
Class Iii ◽  
High Flow Nasal Cannula ◽  
Central Type ◽  
Oxygen Inhalation ◽  
Percutaneous Transluminal

A 62-year-old woman with Wolff-Parkinson-White syndrome was with recent worsening of dyspnea to New York Heart Association functional status Class III. The patient was diagnosed as having central type chronic thromboembolic pulmonary hypertension. By cardiac catheterization, her mean pulmonary artery pressure was 53 mmHg with total pulmonary resistance 2238 dynes·sec·cm−5. After medical therapies with tadalafil, furosemide, ambrisentan, beraprost, and warfarin were initiated, percutaneous transluminal pulmonary angioplasty (PTPA) was performed. Following PTPA, life-threating hypoxemia resulting from postoperative reperfusion pulmonary edema developed. High-flow nasal cannula therapy (HFNC) was applied, and 100% oxygen at 50 L/min of flow was required to keep oxygenation. HFNC was continued for 3 days, and the patient was discharged on 8th postoperative day with SpO2of 97% on 3 L/min of oxygen inhalation. Because of the simplicity of the technique, the lower cost of equipment, and remarkable patient tolerance to the treatment, we speculate that HFNC can take over the post of noninvasive ventilation as first-line therapy for patients with acute respiratory failure.

Sign in / Sign up

Export Citation Format

Share Document